Erratum: Enhanced hypertension prevalence in non-Han Chinese minorities from Xinjiang Province, China (Hypertension Research (2009) 32 (1097-1103) DOI: 10.1038/hr.2009.159);Enhanced hypertension prevalence in non-Han Chinese minorities from Xinjiang Province, China

Hypertension Research

Volumn 32, Issue 12, 2009, Pages 1097-1103

  Lu, Zhensui ^a,b   Lu, Zhenhong ^c   Zhu, Yanling ^d   Yan, Zhaoyang ^e   Liu, Xiaoquan ^d   Yan, Shigui ^a,b   Shi, Guo Ping ^f  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c Xinjiang Petroleum College Hospital   (China)

^d Urumqi First People's Hospital   (China)

^e Xinjiang Industry College Hospital   (China)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Body mass index; Minority; Risk factor

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BODY MASS; CHINA; CHINESE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; LEAN BODY WEIGHT; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MINORITY GROUP; OBESITY; PREVALENCE; RACE DIFFERENCE; RISK FACTOR; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

EID: 73849113815     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2009.204     Document Type: Erratum

References (39)

1. Liao Y, McGee DL, Cooper RS. Prediction of coronary heart disease mortality in blacks and whites: pooled data from two national cohorts. Am J Cardiol 1999; 84: 31-36.
2. People's Republic of China National Blood Pressure Survey Cooperative Group. A survey on the prevalence of hypertension in different ethnic groups in China. Chin J Hypertens 1995; 3: 24-30.
3. Smith Jr SC, Clark LT, Cooper RS, Daniels SR, Kumanyika SK, Ofili E, Quinones MA, Sanchez EJ, Saunders E, Tiukinhoy SD. American Heart Association Obesity, Metabolic Syndrome, and Hypertension Writing Group. Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Obesity, Metabolic Syndrome, and Hypertension Writing Group. Circulation 2005; 111: e134-e139.
4. Siervogel RM, Wisemandle W, Maynard LM, Guo SS, Chumlea WC, Towne B. Lifetime overweight status in relation to serial changes in body composition and risk factors for cardiovascular disease: The Fels Longitudinal Study. Obes Res 2000; 8: 422-430.
5. Wang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr 2005; 81: 555-563.
6. Zhou BF, Wu YF, Yang J, Li Y, Zhang HY, Zhao LC. Overweight is anindependent risk factor for cardiovascular disease in Chinese populations. Obes Rev 2002; 3: 147-156.
7. World Health Organization. The Asia-Pacific Perspective: Redefining Obesity and its Treatment. World Health Organization: Geneva, Switzerland, 2000. http://www.who.int/ bmi/index.jsp?introPageintro-3.html.
8. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157-163.
9. Zhou BF. Cooperative Meta-Analysis Group of the Working Group on Obesity in China. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults-study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci 2002; 15: 83-96.
10. Zhou BF. Predictive values of body mass index and waist circumference for risk factors of certain related disease in Chinese adults: study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Asia Pac J Clin Nutr 2002; 11: S685-S693.
11. Joint National Committee. The seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure (JNC-7). JAMA 2003; 289: 2560-2571.
12. Manson JE, Colditz GA, Stampfer MJ, Willett WC, Rosner B, Monson RR, Speizer FE, Hennekens CH. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 1990; 322: 882-889. (Pubitemid 20108377)
13. He J, Whelton PK, Appel LJ, Charleston J, Klag MJ. Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension 2000; 35: 544-549.
14. Pan WH, Nanas S, Dyer A, Liu K, McDonald A, Schoenberger JA, Shekelle RB, Stamler R, Stamler J. The role of weight in the positive association between age and blood pressure. Am J Epidemiol 1986; 124: 612-623.
15. Kawabe H, Saito I. Influence of age and sex on prevalence of masked hypertension determined from home blood pressure measurements. J Hum Hypertens 2007; 21: 94-95. (Pubitemid 44921824)
16. Tohme RA, Jurjus AR, Estephan A. The prevalence of hypertension and its association with other cardiovascular disease risk factors in a representative sample of the Lebanese population. J Hum Hypertens 2005; 19: 861-868.
17. Zylberstein DE, Bengtsson C, Björkelund C, Landaas S, Sundh V, Thelle D, Lissner L. Serum homocysteine in relation to mortality and morbidity from coronary heart disease: a 24-year follow-up of the population study of women in Gothenburg. Circulation 2004; 109: 601-606.
18. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003; 290: 199-206.
19. Ostchega Y, Carroll M, Prineas RJ, McDowell MA, Louis T, Tilert T. Trends of elevated blood pressure among children and adolescents: data from the National Health and Nutrition Examination Survey1988-2006. Am J Hypertens 2009; 22: 59-67.
20. Sprafka JM, Bender AP, Jagger HG. Prevalence of hypertension and associated risk factors among diabetic individuals. The Three-City Study. Diabetes Care 1988; 11: 17-22.
21. Caterson ID, Hubbard V, Bray GA, Grunstein R, Hansen BC, Hong Y, Labarthe D, Seidell JC, Smith Jr SC. American Heart Association. Prevention Conference VII: Obesity, a Worldwide Epidemic Related to Heart Disease and Stroke: Group III: Worldwide Comorbidities of Obesity. Circulation 2004; 110: e476-e483.
22. McGuire HL, Svetkey LP, Harsha DW, Elmer PJ, Appel LJ, Ard JD. Comprehensive lifestyle modification and blood pressure control: a review of the PREMIER trial. J Clin Hypertens 2004; 6: 383-390.
23. Johnson AG, Nguyen TV, Davis D. Blood pressure is linked to salt intake and modulated by the angiotensinogen gene in normotensive and hypertensive elderly subjects. J Hypertens 2001; 19: 1053-1060.
24. Elliott P, Kesteloot H, Appel LJ, Dyer AR, Ueshima H, Chan Q, Brown IJ, Zhao L, Stamler J. INTERMAP Cooperative Research Group. Dietary phosphorus and blood pressure. International study of macro-and micro-nutrients and blood pressure. Hypertension 2008; 51: 669-675.
25. Schmieder R, Messerli F, Garagavlia G, Nunez B. Dietary salt intake: a determinant of cardiac involvement in essential hypertension. Circulation 1988; 78: 951-956.
26. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller III ER, Simons-Morton DG, Karanja N, Lin PH. DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 344: 3-10. (Pubitemid 32064838)
27. The China Salt Substitute Study Collaborative Group. Salt substitution: a low-cost strategy for blood pressure control among rural Chinese. A randomized, controlled trial. J Hypertens 2007; 25: 2011-2018.
28. Gu D, He J, Wu X, Duan X, Whelton PK. Effect of potassium supplementation on blood pressure in Chinese: a randomized, placebo-controlled trial. J Hypertens 2001; 19: 1325-1331.
29. Karanja NM, Obarzanek E, Lin PH, McCullough ML, Phillips KM, Swain JF, Champagne CM, Hoben KP. Descriptive characteristics of the dietary patterns used in the Dietary Approaches to Stop Hypertension Trial. DASH Collaborative Research Group. Descriptive characteristics of the dietary patterns used in the Dietary Approaches to Stop Hypertension Trial. J Am Diet Assoc 1999; 99: S19-S27.
30. Vollmer WM, Sacks FM, Ard J, Appel LJ, Bray GA, Simons-Morton DG, Conlin PR, Svetkey LP, Erlinger TP, Moore TJ, Karanja N. DASH-Sodium Trial Collaborative Research Group. Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Ann Intern Med 2001; 135: 1019-1028.
31. Bray GA, Vollmer WM, Sacks FM, Obarzanek E, Svetkey LP, Appel LJ. DASH Collaborative Research Group. A further subgroup analysis of the effects of the DASH diet and three dietary sodium levels on blood pressure: results of the DASH-Sodium Trial. Am J Cardiol 2004; 94: 222-227.
32. Elliott P, Stamler J, Dyer AR, Appel L, Dennis B, Kesteloot H, Ueshima H, Okayama A, Chan Q, Garside DB, Zhou B. Association between protein intake and blood pressure: The INTERMAP Study. Arch Intern Med 2006; 166: 79-87.
33. Appel LJ, Sacks FM, Carey VJ, Obarzanek E, Swain JF, Miller III ER, Conlin PR, Erlinger TP, Rosner BA, Laranjo NM, Charleston J, McCarron P, Bishop LM. OmniHeart Collaborative Research Group. Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA 2005; 294: 2455-2464.
34. Stamler J, Neaton JD. The Multiple Risk Factor Intervention Trial (MRFIT) Importance Then and Now. JAMA 2008; 300: 1343-1345.
35. Holmes E, Loo RL, Stamler J, Bictash M, Yap IK, Chan Q, Ebbels T, De Iorio M, Brown IJ, Veselkov KA, Daviglus ML, Kesteloot H, Ueshima H, Zhao L, Nicholson JK, Elliott P. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 2008; 453: 396-400.
36. Elmer PJ, Obarzanek E, Vollmer WM, Simons-Morton D, Stevens VJ, Young DR, Lin PH, Champagne C, Harsha DW, Svetkey LP, Ard J, Brantley PJ, Proschan MA, Erlinger TP, Appel LJ. PREMIER Collaborative Research Group. Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Ann Intern Med 2006; 144: 485-495.
37. Svetkey LP, Erlinger TP, Vollmer WM, Feldstein A, Cooper LS, Appel LJ, Ard JD, Elmer PJ, Harsha D, Stevens VJ. Effect of lifestyle modifications on blood pressure by race, sex, hypertension status, and age. J Hum Hypertens 2005; 19: 21-31.
38. Stehman-Breen CO, Gillen D, Steffes M, Jacobs Jr DR, Lewis CE, Kiefe CI, Siscovick D. Racial Differences in Early-Onset Renal Disease among Young Adults: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. J Am Soc Nephrol 2003; 14: 2352-2357. (Pubitemid 37052383)
39. Mahaney M, Blangero J, Comuzzie A, VandeBerg JL, Stern MP, MacCluer JW. Plasma HDL cholesterol, triglycerides, and adiposity. A quantitative genetic test of the conjoint trait hypothesis in the San Antonio Family Heart Study. Circulation 1995; 92: 3240-3248.